Gurgaon, February 27, 2025 –Medtronic,
a leader in medical technology and Philips, a leader in health technology
announced the signing of a Memorandum of Understanding (MoU) in India, to
educate and train cardiologists and radiologists on advanced imaging techniques
for structural heart diseases. This partnership aims to upskill 300+ clinicians
in multi-modality imaging such as echocardiography (echo) and Magnetic
Resonance Imaging (MRI), especially for End-Stage Renal Disease (ESRD)
patients.
The training program will combine didactic sessions with hands-on
experience delivered on Philips’ cutting-edge ultrasound and MRI systems, under
the guidance of renowned international and Indian experts. 15 key medical
institutions have been identified specialising in structural heart procedures
for these educational workshops.
Speaking on the collaboration Mandeep Singh Kumar, Managing Director and Vice
President of Medtronic India said, “We are excited to
partner with Philips to bring this innovative training initiative to life. This
collaboration represents a significant step forward in our ongoing commitment
to improving patient outcomes, particularly for those with chronic kidney
disease and ESRD. By providing specialised training and advanced imaging
solutions, we aim to equip healthcare professionals with the tools they need to
enhance the precision of TAVI (Transcatheter Aortic Valve Implantation)
procedures and ultimately improve patient care."
“At Philips, every effort we make is centered on providing better care
for more people and this partnership with Medtronic is another step towards our
goal. By focusing on innovation and education in structural heart imaging
across India, we aim to address the rapid advancements in multi-modality
imaging through continuous learning. Our objective is to empower clinicians
with advanced techniques such as echocardiography and MRI, leading to more
accurate diagnoses and improved care outcomes, especially for ESRD patients”,
said Bharath Sesha, Managing Director, Philips Indian Subcontinent.
“As India's healthcare landscape progresses to address its high disease burden,
we remain committed to enhancing clinical expertise and making a meaningful
impact on patient care”.
With the rising incidence of Chronic Kidney Disease (CKD) in India,
adding approximately 2.2 lakh* new cases of ESRD each year, and global
studies** indicating that 9.5% of ESRD patients with Aortic Stenosis can
benefit from advanced imaging technologies during Transcatheter Aortic Valve
Replacement (TAVR), there is a critical need for advanced diagnostic solutions
and specialised training for clinicians.
Medtronic transcatheter aortic valve replacement (TAVR) system recently
celebrated a significant milestone: 20 years since its first-in-human procedure
in 2004. This landmark achievement underscores Medtronic's unwavering
commitment to continuous innovation and commercialisation in the field of
cardiovascular care. Over the past two decades, Medtronic has introduced a
series of groundbreaking TAVR systems in India, consistently pushing the
boundaries of minimally invasive heart valve replacement and improving patient
outcomes.
Philips's AI-driven software, capable of analysing aortic anatomy using
data obtained from 3D transesophageal echocardiography (3D TEE) and MRI,
eliminates the need for radiopaque contrast agents. This innovation is
particularly advantageous for safeguarding kidney health, as contrast agents
can be nephrotoxic and pose a significant risk of further deteriorating kidney
function in ESRD patients. By enabling clinicians to use alternate imaging
approaches, the partnership will significantly improve both the duration and
quality of life for these patients.
*Source - Introduction of Pradhan Mantri
National Dialysis Program (PMNDP)
**Source - https://pubmed.ncbi.nlm.nih.gov/36812906/
For further information, please contact:
Medtronic
Masooma Pathre
Philips
Gunjan Mukherjee
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc,
headquartered in Galway, Ireland, is the leading global healthcare technology
company that boldly attacks the most challenging health problems facing
humanity by searching out and finding solutions. Our Mission — to alleviate
pain, restore health, and extend life — unites a global team of 95,000+
passionate people across more than 150 countries. Our technologies and
therapies treat 70 health conditions and include cardiac devices, surgical
robotics, insulin pumps, surgical tools, patient monitoring systems, and more.
Powered by our diverse knowledge, insatiable curiosity, and desire to help all
those who need it, we deliver innovative technologies that transform the lives
of two people every second, every hour, every day. Expect more from us as we
empower insight-driven care, experiences that put people first, and better
outcomes for our world. In everything we do, we are engineering the
extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow Medtronic on LinkedIn.
Any forward-looking
statements are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and Exchange
Commission. Actual results may differ materially from anticipated results. All
details contained in this release are for general awareness purposes only and
do not constitute medical advice.
About Royal Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company focused on
improving people’s health and well-being through meaningful innovation.
Philips’ patient- and people-centric innovation leverages advanced technology
and deep clinical and consumer insights to deliver personal health solutions
for consumers and professional health solutions for healthcare providers and
their patients in the hospital and the home.
Headquartered in
the Netherlands, the company is a leader in diagnostic imaging, ultrasound,
image-guided therapy, monitoring and enterprise informatics, as well as in
personal health. Philips generated 2024 sales of EUR 18 billion and employs
approximately 67,800 employees with sales and services in more than 100
countries. News about Philips can be found at www.philips.com/newscenter.